ALSO: AZBio Members can get a special rate of $99 (print and online) for 12 months of the Arizona Capitol Times. Don’t Delay! This special offer ends April 29th. Click Here to subscribe with this special offer by April 29th!
One way or another, if Arizona is going to realize its potential, we as Arizonans need to come together to figure how we are going to invest in Arizona’s future.Continue reading
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. Continue reading
Apply Today to MedTech Innovator 2015Applications are due by April 30th!
Seeking Molecular Technologist for full time position with Pharmacogenomic processing experience
Continue reading
FDA and EMA Letters of Support Suggest Valuable Research PotentialContinue reading
By Gabrielle Fimbres, College of Agriculture and Life Sciences | April 8, 2015Continue reading
News Brief for AZBio MembersContinue reading
Simple genetic test by TGen reveals likely causes of disease, after other extensive testing failed; one child’s case produces discoveryContinue reading
By: Howard Fischer, Capitol Media Services April 7, 2015 , 6:00 am (Republished with permission.)
Arizonans who want to want to run their own lab tests will soon be able to do so without first visiting a doctor.
But your insurance company won’t pick up the tab.
HOYA Group has closed financing in Salutaris Medical Devices (SalutarisMD®). SalutarisMD will use the funding to further its growth strategy in developing its patented medical device designed for minimally invasive therapy of wet age-related macular degeneration (wet AMD). Wet AMD is a leading cause of vision loss and blindness that primarily affects older adults.